What did @loulouoren actually say?
In a 263K-view TikTok, @loulouoren walked through a month-by-month timeline for transgender women starting estrogen and testosterone blockers. She described early changes like mood shifts and breast buds in months one to three, noticeable breast growth and fat redistribution by months three to six, and facial changes including a softer jaw and fuller cheeks around month eight. She also mentioned losing her sex drive for six months and noticing decreased muscle mass. The video ends with her realizing she forgot to take her hormones that day, which, honestly, is a more relatable moment than most health influencers allow themselves.
The tone is anecdotal and personal, which is fine. The problem is when personal timelines get presented as universal ones, because in feminizing HRT, the variance between individuals is genuinely wide.
Does the science back this up?
Mostly, yes, with important caveats. The broad timeline she describes is consistent with published clinical guidelines. The Endocrine Society's 2017 guidelines and subsequent literature confirm that breast development, fat redistribution, skin softening, and changes in body hair follow a general arc over the first one to two years. But the specific timing she gives, such as noticeable breast growth by three to six months, overstates the consistency of that window.
Breast development in transfeminine individuals is highly variable. Tangpricha and den Heijer (2017, Lancet Diabetes and Endocrinology) note that breast growth is one of the slowest-changing and most genetically influenced outcomes, often continuing for two or more years, and final breast size frequently falls short of expectations. Her statement that body hair thins while head hair thickens also needs qualification. Testosterone blockers reduce androgenic hair loss, but head hair regrowth is not guaranteed, particularly if follicle damage from prior androgen exposure is already established.
What did they get wrong (or right)?
She got the libido piece right, and it deserves credit because few creators talk about it honestly. Testosterone suppression substantially reduces circulating androgens, which are the primary driver of libido across sexes. A temporary loss of sex drive is well-documented. van Caenegem et al. (2015, Journal of Sexual Medicine) found significant reductions in sexual desire following androgen suppression in transfeminine individuals, with some recovery over time as individuals adjust to the hormonal shift.
She got muscle mass broadly right too. Estrogen therapy combined with testosterone suppression does reduce lean mass and strength. Roberts et al. (2021, British Journal of Sports Medicine) confirmed measurable reductions in muscle mass and strength over the first two years of feminizing HRT.
Where she oversimplified: the jaw softening claim. Facial fat redistribution does occur, and it can make the face appear softer. But the bony jaw structure does not change in adults. What changes is subcutaneous fat distribution, not skeletal remodeling. Framing it as a jaw change can set unrealistic expectations.
What should you actually know?
Feminizing HRT outcomes depend on a genuinely complicated mix of variables. Genetics, the specific antiandrogen used (spironolactone versus cyproterone versus bicalutamide, where available), the form of estrogen, baseline hormone levels, age at start, and adherence all shape how and when changes appear. There is no standard timeline that applies cleanly to everyone.
The Endocrine Society guidelines recommend regular lab monitoring, typically every three months initially, to ensure estradiol levels are in the therapeutic range and that testosterone is adequately suppressed. Changes in dosage based on labs, not on whether TikTok said something should have happened by now, are how clinical decisions should be made. If you are comparing your six-month results to someone else's and feeling behind, that comparison is unlikely to be medically meaningful. It may, however, be emotionally meaningful, which is a different problem worth addressing with a provider or counselor who works with gender-affirming care.
Bottom line: is this video useful or risky?
It is more useful than harmful, which is not a low bar on health TikTok. The creator is transparent that this is her personal experience, she repeatedly acknowledges variation, and she does not recommend specific doses or drugs. But a video this widely viewed will inevitably be read as a clinical benchmark by people who have no other frame of reference. Some of the timeline specifics, particularly around breast growth and the jaw, could cause unnecessary distress if someone's experience diverges. The right context for this video is alongside, not instead of, a conversation with a gender-affirming endocrinologist or primary care provider.